168 related articles for article (PubMed ID: 20431339)
1. Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.
De Groot AS; McClaine E; Moise L; Martin W
Hum Vaccin; 2010 Feb; 6(2):161-63. PubMed ID: 20431339
[No Abstract] [Full Text] [Related]
2. Additional seasonal influenza virus vaccinations for the 2009 H1N1 pandemic.
Qin CF; Jiang T; Han JF; Li XF; Qin ED; Leng QB
Clin Vaccine Immunol; 2010 May; 17(5):887-8. PubMed ID: 20219879
[No Abstract] [Full Text] [Related]
3. Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.
Agrati C; Castilletti C; Cimini E; Lapa D; Quartu S; Caglioti C; Lanini S; Cattoli G; Martini F; Ippolito G; Capobianchi MR
PLoS One; 2014; 9(8):e105651. PubMed ID: 25162670
[TBL] [Abstract][Full Text] [Related]
4. Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.
Aljurayyan A; Puksuriwong S; Ahmed M; Sharma R; Krishnan M; Sood S; Davies K; Rajashekar D; Leong S; McNamara PS; Gordon S; Zhang Q
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563292
[TBL] [Abstract][Full Text] [Related]
5. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
[TBL] [Abstract][Full Text] [Related]
6. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
[TBL] [Abstract][Full Text] [Related]
7. Broadly Protective CD8
Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
J Virol; 2021 May; 95(12):. PubMed ID: 33827939
[TBL] [Abstract][Full Text] [Related]
8. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
[TBL] [Abstract][Full Text] [Related]
9. Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.
Lee YN; Kim MC; Lee YT; Kim YJ; Lee J; Kim C; Ha SH; Kang SM
Antiviral Res; 2015 Oct; 122():82-90. PubMed ID: 26248203
[TBL] [Abstract][Full Text] [Related]
10. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.
Manicassamy B; Medina RA; Hai R; Tsibane T; Stertz S; Nistal-Villán E; Palese P; Basler CF; García-Sastre A
PLoS Pathog; 2010 Jan; 6(1):e1000745. PubMed ID: 20126449
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.
Gras S; Kedzierski L; Valkenburg SA; Laurie K; Liu YC; Denholm JT; Richards MJ; Rimmelzwaan GF; Kelso A; Doherty PC; Turner SJ; Rossjohn J; Kedzierska K
Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12599-604. PubMed ID: 20616031
[TBL] [Abstract][Full Text] [Related]
12. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma.
Hahn M; Schnitzler P; Schweiger B; Kunz C; Ho AD; Goldschmidt H; Schmitt M
Haematologica; 2015 Jul; 100(7):e285-8. PubMed ID: 25820335
[No Abstract] [Full Text] [Related]
14. 2009 H1N1 swine flu: the 2010 perspective.
Bucher D; Tumpey T; Lowen A; Gill J; Shaw M; Matthews J; Galarza J; Arroyo JM; Dormitzer PR
Ann N Y Acad Sci; 2010 Sep; 1205 Suppl 1():E10-20. PubMed ID: 20860673
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.
Tu W; Mao H; Zheng J; Liu Y; Chiu SS; Qin G; Chan PL; Lam KT; Guan J; Zhang L; Guan Y; Yuen KY; Peiris JS; Lau YL
J Virol; 2010 Jul; 84(13):6527-35. PubMed ID: 20410263
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
[TBL] [Abstract][Full Text] [Related]
17. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.
Tan AC; Deliyannis G; Bharadwaj M; Brown LE; Zeng W; Jackson DC
Immunol Cell Biol; 2013 Jan; 91(1):96-104. PubMed ID: 23146941
[TBL] [Abstract][Full Text] [Related]
18. Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses.
Choi A; Ibañez LI; Strohmeier S; Krammer F; García-Sastre A; Schotsaert M
Front Immunol; 2020; 11():1166. PubMed ID: 32582220
[TBL] [Abstract][Full Text] [Related]
19. Serologic status for pandemic (H1N1) 2009 virus, Taiwan.
Huang DT; Shao PL; Huang KC; Lu CY; Wang JR; Shih SR; Chi H; Lai MR; Lee CY; Chang LY; Huang LM
Emerg Infect Dis; 2011 Jan; 17(1):76-8. PubMed ID: 21192858
[TBL] [Abstract][Full Text] [Related]
20. Return of inactivated whole-virus vaccine for superior efficacy.
Furuya Y
Immunol Cell Biol; 2012 Jul; 90(6):571-8. PubMed ID: 21844883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
